title: [Current developments in antiviral chemotherapy. 3: Vidarabine, ganciclovir].
authors.affiliation: Institut für Klinische und Molekulare Virologie, Universität Erlangen-Nürnberg.
authors.forename: T
authors.initials: T
authors.lastname: Stamminger
authors.forename: B
authors.initials: B
authors.lastname: Fleckenstein
mesh_terms: D000328:Adult; D002648:Child; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D015774:Ganciclovir / Q000009:adverse effects / Q000627:therapeutic use*; D006561:Herpes Simplex / Q000188:drug therapy*; D006562:Herpes Zoster / Q000188:drug therapy*; D006801:Humans; D014740:Vidarabine / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D014740:Vidarabine; D015774:Ganciclovir
vernacular_title: Aktuelle Entwicklungen der antiviralen Chemotherapie. Folge 3: Vidarabin, Ganciclovir.